Edgewise Therapeutics, Inc (EWTX) insider trading
Every open-market stock purchase and sale by Edgewise Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Kevin Koch (CEO) and 4 others sold $1.9M in the last 90 days.
- Last insider buy: Jonathan C Fox (Insider), $199K, 11 months ago.
Last 12 months: insiders bought $199K (1 buy) and sold $19.5M (12 sales). Last close $39.65 on Oct 21, 2026.
Recent EWTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Jonathan C Fox (Insider) | Bought (not open market) | — |
| Aug 13, 2026 | Joanne M. Donovan (C-suite exec) | Sold | $127K |
| Aug 12, 2026 | Kevin Koch (CEO) | Sold | $383K |
| Aug 12, 2026 | Kevin Koch (CEO) | Sold | $361K |
| Aug 12, 2026 | Alan J Russell (C-suite exec) | Sold | $141K |
| Aug 12, 2026 | Joanne M. Donovan (C-suite exec) | Sold | $124K |
| Aug 12, 2026 | Joanne M. Donovan (C-suite exec) | Sold | $121K |
| Aug 12, 2026 | Behrad Derakhshan (C-suite exec) | Sold | $108K |
| Aug 12, 2026 | John R Moore (General Counsel) | Sold | $107K |
| Aug 12, 2026 | John R Moore (General Counsel) | Sold | $106K |
| Aug 12, 2026 | Alan J Russell (C-suite exec) | Sold | $99.3K |
| Aug 12, 2026 | Behrad Derakhshan (C-suite exec) | Sold | $95.1K |
| Aug 12, 2026 | Kevin Koch (CEO) | Sold | $40.5K |
| Aug 12, 2026 | Joanne M. Donovan (C-suite exec) | Sold | $35.6K |
| Aug 12, 2026 | Alan J Russell (C-suite exec) | Sold | $17.3K |
| Aug 12, 2026 | Behrad Derakhshan (C-suite exec) | Sold | $13.5K |
| Aug 12, 2026 | Behrad Derakhshan (C-suite exec) | Sold | $6.7K |
| Aug 12, 2026 | Joanne M. Donovan (C-suite exec) | Sold | $4.6K |
| Aug 12, 2026 | John R Moore (General Counsel) | Sold | $4.4K |
| Aug 12, 2026 | John R Moore (General Counsel) | Sold | $2.6K |
| Aug 12, 2026 | John R Moore (General Counsel) | Bought (not open market) | — |
| Aug 12, 2026 | John R Moore (General Counsel) | Bought (not open market) | — |
| Aug 12, 2026 | Kevin Koch (CEO) | Bought (not open market) | — |
| Aug 12, 2026 | Kevin Koch (CEO) | Bought (not open market) | — |
| Aug 12, 2026 | Kevin Koch (CEO) | Bought (not open market) | — |
Who's trading EWTX
- Jonathan C Fox, Insider: bought $199K (1 buy), last Oct 1, 2026
- Joanne M. Donovan, C-suite exec: sold $4.6M (11 sales), last Aug 13, 2026
- Behrad Derakhshan, C-suite exec: sold $223K (4 sales), last Aug 12, 2026
- Kevin Koch, CEO: sold $785K (3 sales), last Aug 12, 2026
- Michael Nofi, CFO: other filings, last Aug 12, 2026
- Alan J Russell, C-suite exec: sold $10.3M (6 sales), last Aug 12, 2026
- John R Moore, General Counsel: sold $220K (4 sales), last Aug 12, 2026
- Peter A. Thompson, 10% owner: other filings, last Jun 5, 2026
- Laura Brege, Insider: other filings, last Jun 5, 2026
- Badreddin Edris, Insider: sold $3.4M (5 sales), last Jun 5, 2026
- Christopher Nathan Martin, Insider: other filings, last Jun 5, 2026
- Arlene Morris, Insider: other filings, last Jun 5, 2026
- Jonathan D Root, Insider: other filings, last Jun 5, 2026
Get free alerts when an insider at Edgewise Therapeutics, Inc files a new trade →